Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3068401000168110 | Naropin 0.75% (ropivacaine hydrochloride 150 mg / 20 mL) injection, 5 x 20 mL ampoules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3068411000168113 | Naropin 0.75% 150 mg/20 mL injection, 5 x 20 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Naropin 0.75% 150 mg/20 mL injection, 5 x 20 mL ampoules | Is a | ropivacaine hydrochloride 150 mg/20 mL injection, 5 x 20 mL ampoules | true | Inferred relationship | Some | ||
| Naropin 0.75% 150 mg/20 mL injection, 5 x 20 mL ampoules | Is a | trade product pack | true | Inferred relationship | Some | ||
| Naropin 0.75% 150 mg/20 mL injection, 5 x 20 mL ampoules | has TPUU | Naropin 0.75% 150 mg/20 mL injection, 20 mL ampoule | true | Inferred relationship | Some | 1 | |
| Naropin 0.75% 150 mg/20 mL injection, 5 x 20 mL ampoules | has TP | Naropin 0.75% | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Naropin 0.75% (ropivacaine hydrochloride 150 mg / 20 mL) injection, 5 x 20 mL ampoules (containered trade product pack) | Is a | True | Naropin 0.75% 150 mg/20 mL injection, 5 x 20 mL ampoules | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR